Peer-Led Intervention for HIV Postpartum Care
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test the efficacy of a theory-driven peer intervention for pregnant and postpartum women living HIV. The peer intervention is designed to increase self-efficacy, social support, self-regulatory behaviors, and outcome expectancy in order to improve retention in care and viral suppression postpartum. The intervention will consist of face-to-face prenatal educational sessions, starting in early third trimester, and postpartum sessions scheduled up to three months postpartum.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment WISH Adherence, WISH Parenting for HIV postpartum care?
Research shows that interventions focusing on parenting and self-care, like the IMAGE program, can improve parenting practices and family outcomes for mothers living with HIV. Additionally, peer-counselor support has been shown to enhance medication adherence in similar contexts, suggesting that peer-led interventions may be beneficial for postpartum care.12345
Is the peer-led intervention for HIV postpartum care safe for humans?
The studies reviewed focus on the effectiveness of peer-led interventions for improving adherence to HIV treatment and retention in care, but they do not report any specific safety concerns related to the intervention itself. This suggests that the intervention is generally considered safe for participants.14678
How does the WISH Adherence and WISH Parenting treatment for HIV postpartum care differ from other treatments?
The WISH Adherence and WISH Parenting treatment is unique because it involves peer-led interventions that focus on social support and community engagement, rather than just medical treatment. This approach aims to improve adherence to HIV care and parenting practices by addressing social and cultural barriers, which are often overlooked in traditional medical treatments.4591011
Eligibility Criteria
This trial is for women living with HIV who are in their 2nd or 3rd trimester of pregnancy. They must be able to give informed consent, read and speak English, have access to a cell phone, and be at least 16 years old. Women planning to move out of the country within a year after giving birth cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Intervention
Participants attend 3 face-to-face prenatal sessions with a peer facilitator to address barriers to outcome expectancies and self-efficacy.
Postpartum Intervention
Participants attend 2 face-to-face postpartum sessions to develop skills for ART adherence and engagement in HIV care.
Follow-up
Participants are monitored for retention in care and viral suppression up to 1 year postpartum.
Treatment Details
Interventions
- WISH Adherence
- WISH Parenting
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator